Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative cytokinetics: cellular response to cell cycle specific agents

J W Gray

    Pharmacology & Therapeutics
    |January 1, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response to: 'Interpreting the guidelines for cleaning up after carbapenemase-producing organisms: the devil's in the dilution'.

    The Journal of hospital infection·2016
    Same author

    The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.

    Oncogene·2016
    Same author

    Cleaning up after carbapenemase-producing organisms.

    The Journal of hospital infection·2016
    Same author

    Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.

    Oncogene·2016
    Same author

    The protected environment for high-risk haematology patients: as safe as we think?

    The Journal of hospital infection·2016
    Same author

    How do you solve a problem like multidrug-resistant Gram-negative bacteria?

    The Journal of hospital infection·2015
    Same journal

    Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

    Pharmacology & therapeutics·2026
    Same journal

    Nipocalimab and other FcRn blockers in neuromuscular disorders.

    Pharmacology & therapeutics·2026
    Same journal

    C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

    Pharmacology & therapeutics·2026
    Same journal

    The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

    Pharmacology & therapeutics·2026
    Same journal

    Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

    Pharmacology & therapeutics·2026
    Same journal

    The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

    Pharmacology & therapeutics·2026
    See all related articles